CX3CR1 and memory impairment: On the other hand, Aβ administration leads to an increase in CX3CR1 levels [110] When the CX3CR1 expression is diminished, Aβ-induced microglial activation, synaptic plasticity blockade, and memory impairment are also reduced [110, 115].